Lv1
60 积分 2024-03-05 加入
Validation for soluble C5b-9 detection and comparative analysis of three quantification methods
15小时前
待确认
Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice
15小时前
已完结
Considerations for Assessment of Reproductive and Developmental Toxicity of Oligonucleotide-Based Therapeutics
1天前
已完结
Recommendations for Safety Pharmacology Evaluations of Oligonucleotide-Based Therapeutics
1天前
已完结
Considerations for the Characterization and Interpretation of Results Related to Alternative Complement Activation in Monkeys Associated with Oligonucleotide-Based Therapeutics
1天前
已完结
OSWG Recommendations for Genotoxicity Testing of Novel Oligonucleotide-Based Therapeutics
1天前
已完结
A First-in-Human, Phase 1 Study to Assess the Pharmacodynamic Properties of Single-Dose Iptacopan (CLNP023X2101)
2天前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
2个月前
已完结
Ivonescimab in advanced NSCLC: is progression-free survival enough, or are overall survival data also needed?
2个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
2个月前
已完结
皖公网安备34019202002308
